Action number: CA21135
Grantee name: Tina Kolenc Milavec
Dissemination: During my 2-months long stay at the University Medical Center in Amsterdam, in the group of Febe van Maldegem, PhD, I learnt all about the Imaging mass cytometry (IMC). This novel technique enables us to determine spatial characteristics of a tissue and observe interactions between cells. I was using IMC to determine changes in the interactions within the glioblastoma microenvironment, which arise from applying treatment (radiotherapy and/or chemotherapy) to glioblastoma organoids. Understanding how cell interactions change after therapy will hopefully help us to unveil the mechanisms underlying therapy resistance.
Tina Kolenc Milavec (left) and PhD student Sofie Koomen (right) trying to prepare organoids from the lung cancer tissue we obtained from a patient after surgery.
Me (Tina) in the laboratory, doing staining of FPPA-fixed glioblastoma tissue slices with the antibody mix for IMC analysis.
Me (left) and Sofie Koomen (right) at the Spring conference of the Dutch Society for immunology (NVVI) in Tiel, Netherlands. I sure learnt a lot of new things about immunology.
Short news/reports about the STSM were also posted on Instagram and LinkedIn.
